D'ALESSIO, Andrea
 Distribuzione geografica
Continente #
AS - Asia 463
NA - Nord America 331
EU - Europa 256
SA - Sud America 74
AF - Africa 44
OC - Oceania 1
Totale 1.169
Nazione #
US - Stati Uniti d'America 313
SG - Singapore 182
HK - Hong Kong 126
BR - Brasile 69
IT - Italia 57
CN - Cina 51
RU - Federazione Russa 45
BJ - Benin 37
DE - Germania 36
VN - Vietnam 31
GB - Regno Unito 24
KR - Corea 22
FR - Francia 16
IN - India 16
AT - Austria 13
IE - Irlanda 12
CA - Canada 11
JP - Giappone 9
NL - Olanda 8
SE - Svezia 8
BD - Bangladesh 7
FI - Finlandia 7
PL - Polonia 7
UA - Ucraina 7
CZ - Repubblica Ceca 4
ES - Italia 4
TR - Turchia 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
EG - Egitto 3
LT - Lituania 3
MX - Messico 3
PK - Pakistan 3
BG - Bulgaria 2
CH - Svizzera 2
ID - Indonesia 2
ZA - Sudafrica 2
BE - Belgio 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
IL - Israele 1
IQ - Iraq 1
KZ - Kazakistan 1
MA - Marocco 1
NR - Nauru 1
PH - Filippine 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 1.169
Città #
Hong Kong 126
Singapore 93
Ashburn 60
Cotonou 37
Beijing 30
Los Angeles 30
Seoul 22
New York 16
Ho Chi Minh City 14
São Paulo 13
Assago 12
Dublin 12
Nuremberg 12
Buffalo 11
Moscow 11
Denver 10
Santa Clara 10
Brooklyn 8
Hanoi 8
Stockholm 8
Tokyo 8
Amsterdam 7
Frankfurt am Main 7
Helsinki 7
London 7
Vienna 7
Warsaw 7
Chennai 6
Boardman 5
Chicago 5
Falkenstein 5
Poplar 5
Turin 5
Ankara 4
Mezzomerico 4
Milan 4
Novara 4
Orem 4
Roubaix 4
Atlanta 3
Belo Horizonte 3
Boston 3
Manchester 3
Munich 3
Pardubice 3
Toronto 3
Uberlândia 3
Bexley 2
Cairo 2
Da Nang 2
Dallas 2
Deiva Marina 2
Delhi 2
Florence 2
Houston 2
Johannesburg 2
Louisville 2
Mexico City 2
Montreal 2
Mumbai 2
New Delhi 2
Paris 2
Phoenix 2
Recife 2
Rome 2
San Francisco 2
Secaucus 2
Tianjin 2
Uzzano 2
Valduggia 2
Vercelli 2
Zurich 2
Agrolândia 1
Almaty 1
Anápolis 1
Apollo 1
Araxá 1
Baghdad 1
Belford Roxo 1
Belém 1
Betim 1
Bismarck 1
Boca Raton 1
Bogor 1
Bom Jesus do Itabapoana 1
Brasília 1
Brussels 1
Cabo Frio 1
Cabreúva 1
Calgary 1
Camboriú 1
Campina Grande do Sul 1
Caraguatatuba 1
Carney 1
Chaguanas 1
Charlotte 1
Cleveland 1
Conceição do Almeida 1
Concord 1
Concordia 1
Totale 750
Nome #
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study 76
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma 61
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis 53
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma 53
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations 52
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab 49
Cumulative radiation exposure from radiological imaging in patients with Hodgkin and diffuse large b-cell lymphoma not submitted to radiotherapy 49
Effective and organ doses in patient undergoing interventional neuroradiology procedures: A multicentre study 48
Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape? 48
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma 48
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study 47
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma 46
PETAL protocol: A phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma 46
Reply 44
. Optimisation of protection in the medical exposure of recurrent adult patients due to computed tomography procedures: development of recurrent exposures reference levels. 42
Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma: A network metanalysis of phase III trials 41
Differential prognostic effect of systemic inflammation in patients with non–small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial 40
A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions 40
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study 39
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study 38
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study 38
Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma 38
The systemic inflammatory response identifies patients with adverse clinical outcome from immunotherapy in hepatocellular carcinoma 37
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma 33
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma 32
Reply 31
Dissecting the Tumor Microenvironment to Predict Immunotherapy Response in Hepatocellular Cancer 28
Totale 1.197
Categoria #
all - tutte 8.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024125 30 0 10 7 20 0 14 4 0 3 5 32
2024/2025490 6 2 46 4 5 66 58 41 76 79 32 75
2025/2026582 61 51 69 166 210 25 0 0 0 0 0 0
Totale 1.197